Natural Snake Venom Inhibitors and their Pharmaceutical Uses: Challenges and Possibilities

  • Saavedra S
  • Avila L
  • Giudicessi S
  • et al.
7Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

© 2018 Bentham Science Publishers. Nowadays, treatment with specific antivenins is considered the only cure for snakebites accidents. However, access to antivenom obstructs the successful implementation of the World Health Organization international guidelines. In the last few years, natural organic compounds, peptides, and proteins with the ability to inhibit snake toxins and obtained from different sources such as plant extracts and animal blood have been proposed as antivenoms. In this work, we will focus on the inhibitors of the main venom toxins, phospholipases A2 and metalloproteinases, and their application as novel antivenoms.

Cite

CITATION STYLE

APA

Saavedra, S. L., Avila, L., Giudicessi, S. L., Albericio, F., Camperi, S. A., Cascone, O., & Martinez-Ceron, M. C. (2018). Natural Snake Venom Inhibitors and their Pharmaceutical Uses: Challenges and Possibilities. Current Pharmaceutical Design, 24(16), 1737–1747. https://doi.org/10.2174/1381612824666180223172854

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free